Akebia Therapeutics (NASDAQ:AKBA) Hits New 52-Week High Following Earnings Beat
Akebia Therapeutics, Inc. (NASDAQ:AKBA – Get Free Report) hit a new 52-week high during mid-day trading on Thursday after the company announced better than expected quarterly earnings. The stock traded as high as $2.90 and last traded at $2.62, with a volume of 4867572 shares. The stock had previously closed at $2.46. The biopharmaceutical company […]
Akebia Therapeutics, Inc. (NASDAQ:AKBA – Get Free Report) hit a new 52-week high during mid-day trading on Thursday after the company announced better than expected quarterly earnings. The stock traded as high as $2.90 and last traded at $2.62, with a volume of 4867572 shares. The stock had previously closed at $2.46. The biopharmaceutical company […]
